deflazacort has been researched along with c-peptide in 2 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (c-peptide) | Trials (c-peptide) | Recent Studies (post-2010) (c-peptide) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 9,053 | 1,632 | 2,445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, A; Cavallo-Perin, P; Cesco, L; Imbimbo, B; Pagano, G | 1 |
| Andreani, D; Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fioriti, E; Lucentini, L; Pozzilli, P; Signore, A; Visalli, N | 1 |
2 trial(s) available for deflazacort and c-peptide
| Article | Year |
|---|---|
Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone.
Topics: Adult; Betamethasone; Blood Glucose; C-Peptide; Double-Blind Method; Female; Glucocorticoids; Glucose Tolerance Test; Humans; Insulin; Male; Prednisone; Pregnenediones; Reference Values | 1989 |
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Niacinamide; Pregnenediones | 1994 |